Application no. and date | 18711796.5 (espacenet) (Federated) (European Patent Register), 20180308 | Patent/reg. no. and date | DK/EP 3592742, 20210519 | Publication date | 20200115 | Priority no. and date | US 201762469073 P, 20170309 | EP pub. no. and date |
EP 3592742 20200115 | Effective date | | Applicant/owner | Theravance Biopharma R&D IP, LLC, 901 Gateway Boulevard
South San Francisco, CA 94080, US | Applicant ref. no. | BT/GP/165057 | Inventor | FATHEREE, Paul R., 921 Minnesota Street
San Francisco, California 94107, US, BRANDT, Gary E. L., 2160 Buena Vista Avenue
Alameda, California 94501, US, VAN ORDEN, Lori Jean, 362 Park Street
San Francisco, California 94110, US, SMITH, Cameron, 4256 Shelter Creek Lane
San Bruno, California 94066, US, SULLIVAN, Steven D.E., 1417 17th Avenue
San Francisco, California 94122, US, KLEINSCHEK, Melanie A., 30 Elizabeth Street
San Francisco, California 94110, US, CRATER, Glenn D., 7108 Rippling Stone Lane
Raleigh, North Carolina 27612, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/397 (2006.01) , A61K 31/437 (2006.01) , A61P 11/00 (2006.01) , C07D 471/04 (2006.01) | Title | JAK inhibitorer med en 4-leddet heterocyclisk amid | Int. application no. | US2018021489 | Int. publication no. | WO2018165392 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|